About
Technology
Issues
FAQ
Links
Official Page
Safety and Efficacy of Venetoclax (VEN) in Combination with Bendamustine (B) Plus Rituximab (R) or Obinutuzumab (G) in Patients (pts) with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results from a Phase Ib Study (GO28440)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.